Kirk Jensen

发表

Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)

E. Kebebew, M. Walter, A. Tobey, 2019, Front. Oncol..

Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy

M. Walter, K. Burman, L. Wartofsky, 2020, Journal of clinical medicine.

Thyroid Fine Needle Aspiration Biopsies in Children: Study of Cytological-Histological Correlation and Immunostaining with Thyroid Peroxidase Monoclonal Antibodies

V. Vasko, A. Bauer, Kirk Jensen, 2010, International journal of pediatric endocrinology.

Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models

D. van Nostrand, K. Burman, L. Wartofsky, 2017, Endocrine connections.

Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells.

Dennis P. McDaniel, K. Burman, Aneeta Patel, 2017, Endocrine-related cancer.

BRAFV600E Mutation Analysis from May-Grünwald Giemsa-Stained Cytological Samples as an Adjunct in Identification of High-Risk Papillary Thyroid Carcinoma

J. Klubo-Gwiezdzinska, A. Bauer, Aneeta Patel, 2011, Endocrine pathology.

Metformin Attenuates 131 I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer

M. Mete, D. Nostrand, K. Burman, 2016 .

Human herpes simplex viruses in benign and malignant thyroid tumours

M. Saji, A. Bauer, Aneeta Patel, 2010, The Journal of pathology.

GABA Receptor Expression in Benign and Malignant Thyroid Tumors

S. Roberts, G. Francis, Kirk Jensen, 2009, Pathology & Oncology Research.

The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.

K. Burman, J. Klubo-Gwiezdzinska, Aneeta Patel, 2014, The Journal of clinical endocrinology and metabolism.

Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer.

A. Bauer, Aneeta Patel, Kirk Jensen, 2010, Experimental and therapeutic medicine.

Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells

G. Kaltsas, K. Burman, L. Wartofsky, 2019, International journal of oncology.

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.

P. Hou, V. Vasko, M. Xing, 2008, The Journal of clinical endocrinology and metabolism.

Glucose-deprivation increases thyroid cancer cells sensitivity to metformin.

Dennis P. McDaniel, K. Burman, L. Wartofsky, 2015, Endocrine-related cancer.

Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm

Justin M Wells, Aneeta Patel, Kirk Jensen, 2021, Therapeutic advances in endocrinology and metabolism.

Microfluidic Droplet Digital PCR Is a Powerful Tool for Detection of BRAF and TERT Mutations in Papillary Thyroid Carcinomas

K. Burman, L. Wartofsky, C. Gomes-Lima, 2019, Cancers.

Inadvertent Radiation Exposures in Combat Zones: Risk of Contamination and Radiobiologic Consequences.

Kirk Jensen, V. Vasko, 2022, Military medicine.

Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis.

J. Klubo-Gwiezdzinska, A. Bauer, Aneeta Patel, 2011, Endocrine-related cancer.

Targeted therapies in thyroid cancer: an extensive review of the literature

K. Burman, Kirk Jensen, V. Vasko, 2016, Expert review of clinical pharmacology.

Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.

K. Burman, L. Wartofsky, J. Klubo-Gwiezdzinska, 2012, Endocrine-related cancer.

Transient hypothyroidism in premature infants after short-term topical iodine exposure: an avoidable risk?

J. Pinsker, A. Bauer, Kirk Jensen, 2013, Pediatrics and neonatology.

Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer

K. Burman, L. Wartofsky, D. Ylli, 2020, Cancers.

Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer

Rebecca J. Brown, Kirk Jensen, S. Kushchayev, 2022, Cancers.

Repositioning therapy for thyroid cancer: new insights on established medications.

K. Burman, Kirk Jensen, V. Vasko, 2014, Endocrine-related cancer.

Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer.

M. Mete, K. Burman, L. Wartofsky, 2016, Thyroid.

Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.

M. Mete, K. Burman, L. Wartofsky, 2013, The Journal of clinical endocrinology and metabolism.

Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?

J. Jonklaas, V. Vasko, Leila Shobab, 2021, Frontiers in Endocrinology.

The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress.

K. Burman, L. Wartofsky, J. Klubo-Gwiezdzinska, 2012, The Journal of endocrinology.

Title: "The expression of translocator protein in human thyroid cancer and its role in the

J. Klubo-Gwiezdzinska, Kirk Jensen, 2012 .

Repositioning therapy for thyroid cancer: new insights on established medications.

K. Burman, Kirk Jensen, V. Vasko, 2014, Endocrine-related cancer.

Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer

Leila Shobab, Kirk Jensen, V. Vasko, 2024, Cancers.

Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer

M. Mete, K. Burman, L. Wartofsky, 2016 .

Editorial: Translational research in thyroid cancer, Volume II

Kirk Jensen, V. Vasko, S. Cheng, 2023, Frontiers in Endocrinology.